S&P 500, Nasdaq, Dow futures rise as US and Iran call a halt to attacks

June 29, 2026

Breaking News

Image source: Pexels

US stock futures climbed on Monday following reports that the US and Iran have agreed to stop tit-for-tat attacks that broke out over the weekend, enabling peace talks to continue.

Nasdaq 100 futures rose 1.2%, while those on the S&P 500 moved up 0.8%, after both indexes closed out last week with sharp losses.

Contracts on the Dow Jones Industrial Average, which is less exposed to tech names, put on roughly 0.4%.

Markets headed into a holiday-shortened week on edge after the US launched strikes on Iranian military targets over the weekend, which escalated tensions in the Middle East and renewed concerns over a hit to global energy supplies.

The strikes came after Washington said Tehran carried out attacks along the Strait of Hormuz.

President Donald Trump later warned of further military action, writing on Truth Social that the US may "militarily complete the job that we very successfully started. If that happens, the Islamic Republic of Iran will no longer exist!" Yahoo Finance reports.

EdgeUp

💊 AbbVie stock run lifts pricing on $10.9 billion Apogee deal to six times cost

U.S. cash equities didn’t trade Sunday, so AbbVie’s most recent close is Friday at $253.35.

That’s a 4.2% gain for the day and up 17.0% since June 18, which was the last session ahead of the Juneteenth break and before AbbVie’s deal week kicked off.

The scale stands out. With 1.77 billion shares out, going from $216.49 to $253.35 pushed market value up around $65 billion.

AbbVie said it will buy Apogee for $10.9 billion in cash.

Apogee closed Friday at $132.55, about 1.9% under the $135.11 cash offer. TechStock² reports.

🍎 Apple shares hold steady as buyback talk meets AI chip strain

Apple Inc. starts Monday trading facing another hurdle for investors—seeing if its buyback will still help earnings per share as memory costs shift from a supply side problem to one coming out of Washington.

Volume tells the story this time. Apple traded at five times its 65-day average turnover on Friday, though the shares had already bounced off a $274.21 low.

The stock is still down 4.45% for the week and 7.36% in a month.

The recovery hasn’t undone that earlier drop. TechStock² reports.

✈️ Palantir and Surf Air Mobility Expand Partnership. Surf Air soars in pre-market

Palantir Technologies today announced an expansion of its partnership with Surf Air Mobility, a leading air mobility platform.

Under the expanded agreement, Palantir and Surf Air Mobility are committing additional resources to accelerate the development and commercial release of SurfOS, including OperatorOS, OwnerOS, and SurfOS Enterprise Solutions products.

The expanded partnership builds on the successful commercial launch of BrokerOS and the recent announcement of a multi-million-dollar contract with Wheels Up, a leading provider of on-demand private aviation, to be the launch customer for Enterprise BrokerOS. Businesswire reports.

🧊 NN, Inc. Announces Significant New Awards for its NVIDIA Data Center Liquid Cooled Products Business. Stock up in pre-market

NN, Inc., a global diversified industrial company that engineers and manufactures high-precision components and assemblies with Six Sigma quality, today provided an update on its rapidly growing Data Center business.

NN’s combined Data Center and Electric Grid business is already its second-largest business, with a further goal to grow the business into the company’s largest business by sales.

The Data Center & Electric Grid end markets are top targeted growth markets for the company, along with Medical products and Defense and Electronics products. Globe Newswire reports.

💊 Universe Pharmaceuticals Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

Universe Pharmaceuticals Inc., a pharmaceutical producer and distributor in China, today announced that the company has entered into a share purchase agreement to acquire 100% of the issued shares of Best Praise International Limited, a company that holds five patents in China with potential applications in pharmaceutical development, for a total purchase price of $10,751,000, payable in the form of 4,376,552 Class A ordinary shares of the company.

The patent portfolio covers several pharmaceutical and healthcare-related areas, including age-related diseases, neurodegenerative conditions, cognitive disorders, cardiovascular-related pharmaceutical applications, antibacterial compounds, and drug delivery technologies. Globe Newswire reports.

Top 5 Movers in Early Pre-Market

(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM ET). Stock Analysis reports.

1) UPC: Universe Pharmaceuticals INC
Total gain: +160.14%

2) DCOY: Decoy Therapeutics Inc.
Total gain: +114.39%

3) NNBR: NN, Inc.
Total gain: +51.09%

4) CMCSA: Comcast Corporation
Total gain: +22.44%

5) IRDM: Iridium Communications Inc.
Total gain: +20.82%

Friday’s Biggest Movers

The closing price of the top three market percent gainers trading near or above $3 on June 26.

(All pricing and percent gains are based on regular market trading hours from 9:30 AM to 4:00 PM ET) Stock Analysis reports.

1) ZCMD: Zhongchao Inc.
Total gain: +161.76%
The company announced that the Company will effectuate a 1-for-3 share consolidation of the Company's ordinary shares of US$0.248 par value each (the "Share Consolidation"). PR Newswire reports.

2) HON: Honeywell International Inc.
Total gain: +100.84%
The company announced strategic growth vertical, leveraging its portfolio of solar and battery energy storage sites to support the next generation of digital infrastructure, milestones like SB 13-2 reinforce the operational track record and site development expertise that will serve as the foundation for that expansion. PR Newswire reports.

3) WSHP: WeShop Holdings Limited
Total gain: +69.85%
The stock appeared to be moving on no notable news.

Today’s Notable Earnings

(Estimate and Actual numbers represent Earnings Per Share in US Dollars)

AVAV: AeroVironment
Q4 2026
After Market Close
Estimate: 1.480
Actual: N/A

ELTP: Elite Pharmaceuticals
Q4 2026
After Market Close
Estimate: N/A
Actual: N/A

PETV: PetVivo Hldgs
Q4 2026
After Market Close
Estimate: N/A
Actual: N/A

Parting Thoughts

“If you want to improve, be content to be thought foolish and stupid.”

– Epictetus

Sourced in: Enchiridion — GoodReads.

Disclaimer

TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).

TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference.

The information in this newsletter summarizes the latest market activity and related news and are provided for educational purposes only. Any trading symbols displayed are for illustrative purposes only and do not constitute a recommendation by TradeZero to buy, sell, or hold any investment. This material is not intended to provide investment advice or to take into account any individual’s financial condition, investment objectives, or requirements.

Investing involves risk, including the possible loss of principal.

There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses.

Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.

Stocks experiencing significant price volatility may involve substantial risk. Past performance is no guarantee of future results.

Any trading strategies discussed are for educational purposes only and should not be construed as investment advice or a recommendation.

Certain information herein has been obtained from third-party sources believed to be reliable; however, its accuracy or completeness cannot be guaranteed. The views and opinions expressed are those of the author and do not necessarily reflect the views or opinions of TradeZero, its affiliates, or employees.

If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.